These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1983834)

  • 1. Interferon in clinically stable, replicative chronic hepatitis B: good news for some.
    Koff RS
    Gastroenterology; 1991 Jan; 100(1):277-9. PubMed ID: 1983834
    [No Abstract]   [Full Text] [Related]  

  • 2. Simultaneous steroids/interferon therapy in chronic hepatitis B.
    Causse X; Godinot H; Chevallier M; Chossegros P; Zoulim F; Zarski JP; Meschiewitz C; Albrecht J; Trépo C
    J Hepatol; 1993 Jan; 17(1):128-9. PubMed ID: 8445212
    [No Abstract]   [Full Text] [Related]  

  • 3. Specific vaccine therapy in chronic hepatitis B infection.
    Pol S; Driss F; Michel ML; Nalpas B; Berthelot P; Brechot C
    Lancet; 1994 Jul; 344(8918):342. PubMed ID: 7914291
    [No Abstract]   [Full Text] [Related]  

  • 4. Persistent hepatitis B virus following interferon alfa therapy and liver transplantation.
    Lavine JE; Lake JR; Ascher NL; Ferrell LD; Ganem D; Wright TL
    Gastroenterology; 1991 Jan; 100(1):263-7. PubMed ID: 1983831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon for hepatitis B: US experience.
    Perrillo RP
    Gut; 1993; 34(2 Suppl):S95-6. PubMed ID: 8314498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic viral hepatitis--benefits of current therapies.
    Hoofnagle JH; Lau D
    N Engl J Med; 1996 May; 334(22):1470-1. PubMed ID: 8618588
    [No Abstract]   [Full Text] [Related]  

  • 7. Glomerulonephritis caused by chronic hepatitis B virus infection: treatment with recombinant human alpha-interferon.
    Lisker-Melman M; Webb D; Di Bisceglie AM; Kassianides C; Martin P; Rustgi V; Waggoner JG; Park Y; Hoofnagle JH
    Ann Intern Med; 1989 Sep; 111(6):479-83. PubMed ID: 2774373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivation of hepatitis B virus infection induced by interferon (IFN) in HBsAg-positive, antiHCV-positive patients.
    Villa E; Grottola A; Trande P; Seium Y; Rebecchi AM; Dugani A; Manenti F
    Lancet; 1993 May; 341(8857):1413. PubMed ID: 7684479
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes in serum and histology of patients with chronic hepatitis B after interferon alpha-2b treatment.
    Han HL; Lang ZW
    World J Gastroenterol; 2003 Jan; 9(1):117-21. PubMed ID: 12508364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with ARA-AMP and interferon of chronic active hepatitis B. Interim analysis of an ongoing study.
    Trépo C; Rougier P; Bizollon T; Poupon R; Zarski JP; Quinton A; Miguet JP; Causse X; Chossegros P; Chevallier M
    J Hepatol; 1991; 13 Suppl 1():S3. PubMed ID: 1720439
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis B viral kinetics: a dynamic puzzle still to be resolved.
    Neumann AU
    Hepatology; 2005 Aug; 42(2):249-54. PubMed ID: 16025494
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B.
    Hoofnagle JH; Peters M; Mullen KD; Jones DB; Rustgi V; Di Bisceglie A; Hallahan C; Park Y; Meschievitz C; Jones EA
    Gastroenterology; 1988 Nov; 95(5):1318-25. PubMed ID: 3049216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged treatment of children with chronic hepatitis B with recombinant alpha 2a-interferon: a controlled, randomized study.
    Utili R; Sagnelli E; Galanti B; Aprea L; Cesaro G; Digilio L; Filippini P; Felaco FM; Gaeta GB; Marrone A
    Am J Gastroenterol; 1991 Mar; 86(3):327-30. PubMed ID: 1998314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited benefits of INF-alpha therapy in renal graft candidates with chronic viral hepatitis B or C.
    Rodrigues A; Morgado T; Areias J; Silvestre F; Pinho L; Alves H; Castro-Henriques A; Sarmento A; Guimarães S
    Transplant Proc; 1997; 29(1-2):777-80. PubMed ID: 9123522
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitative assessment of serum IgM anti-HBc in the natural course and during interferon treatment of chronic hepatitis B virus infection.
    Marinos G; Smith HM; Naoumov NV; Williams R
    Hepatology; 1994 Feb; 19(2):303-11. PubMed ID: 8294088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The summarized of EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.
    Idilman R
    Turk J Gastroenterol; 2017 Sep; 28(5):412-416. PubMed ID: 28936972
    [No Abstract]   [Full Text] [Related]  

  • 17. Overview of HBV therapy.
    Pessoa MG; Wright TL
    Adv Exp Med Biol; 1999; 458():1-10. PubMed ID: 10549374
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment with recombinant alpha 2b-interferon of chronic HDV hepatitis in children.
    Craxì A; Di Marco V; Volpes R; Marra S; Rizzetto M; Rosina F; Barbera C; Bortolotti F; Crivellaro C; Iannuzzi C
    Prog Clin Biol Res; 1991; 364():399-404. PubMed ID: 2020715
    [No Abstract]   [Full Text] [Related]  

  • 19. A multicentre randomized clinical trial of recombinant alpha-2a interferon therapy in patients with chronic hepatitis B.
    Rumi M; Romeo R; De Filippi F; Marcelli R; Del Ninno E; van Eyken P; Desmet V; Colombo M
    Ital J Gastroenterol; 1993 Apr; 25(3):117-20. PubMed ID: 8507888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus replication patterns after orthotopic liver transplantation: de novo versus recurrent infection.
    Douglas DD; Rakela J; Taswell HF; Krom RA; Wiesner RH
    Transplant Proc; 1993 Apr; 25(2):1755-7. PubMed ID: 8470154
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.